Chemotherapy-induced anorexia is accompanied by activation of brain pathways signaling dehydration

Physiology and Behavior

Volumn 101, Issue 5, 2010, Pages 639-648

  Sinno, Maria Hamze ^a   Coquerel, Quentin ^a   Boukhettala, Nabile ^a   Coëffier, Moïse ^a,b   Gallas, Syrine ^a   Terashi, Mutsumi ^a   Ibrahim, Ayman ^a   Breuillé, Denis ^c   Déchelotte, Pierre ^a,b   Fetissov, Sergueï O ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

Body weight; Brain; Cancer chemotherapy; Cytokines; Food intake; Hypothalamus; Intestinal inflammation; Neuropeptides; Peptide hormones; Water intake

Indexed keywords

INTERLEUKIN 1BETA; MESSENGER RNA; METHOTREXATE; PROOPIOMELANOCORTIN; PROTEIN C FOS; VASOPRESSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; ARTICLE; CONTROLLED STUDY; DEHYDRATION; DIARRHEA; FLUID INTAKE; FOOD INTAKE; GENE EXPRESSION; HYPOTHALAMUS; MALE; MICROGLIA; MUCOSA INFLAMMATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; ANOREXIA; ANTINEOPLASTIC AGENTS; APPETITE; BODY WEIGHT; DEHYDRATION; DRINKING; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-1BETA; MALE; METHOTREXATE; PRO-OPIOMELANOCORTIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; RATS, ZUCKER; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 78149258910     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.09.016     Document Type: Article

References (73)

1. Blijlevens N.M. Implications of treatment-induced mucosal barrier injury. Curr Opin Oncol 2005, 17:605-610.
2. Osoba D., Zee B., Warr D., Kaizer L., Latreille J., Pater J. Quality of life studies in chemotherapy-induced emesis. Oncology 1996, 53(Suppl 1):92-95.
3. Sonis S.T. Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity. Oral Oncol 1998, 34:39-43.
4. Van Cutsem E., Arends J. The causes and consequences of cancer-associated malnutrition. Eur J Oncol Nurs 2005, 9(Suppl 2):S51-S63.
5. Konsman J.P., Blomqvist A. Forebrain patterns of c-Fos and FosB induction during cancer-associated anorexia-cachexia in rat. Eur J Neurosci 2005, 21:2752-2766.
6. Laviano A., Inui A., Marks D.L., Meguid M.M., Pichard C., Rossi Fanelli F., et al. Neural control of the anorexia-cachexia syndrome. Am J Physiol Endocrinol Metab 2008, 295:E1000-E1008.
7. Perboni S., Bowers C., Kojima S., Asakawa A., Inui A. Growth hormone releasing peptide 2 reverses anorexia associated with chemotherapy with 5-fluoruracil in colon cancer cell-bearing mice. World J Gastroenterol 2008, 14:6303-6305.
8. Seruga B., Zhang H., Bernstein L.J., Tannock I.F. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer 2008, 8:887-899.
9. Dantzer R., O'Connor J.C., Freund G.G., Johnson R.W., Kelley K.W. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008, 9:46-56.
10. Guijarro A., Laviano A., Meguid M.M. Hypothalamic integration of immune function and metabolism. Prog Brain Res 2006, 153:367-405.
11. Thaler J.P., Choi S.J., Schwartz M.W., Wisse B.E. Hypothalamic inflammation and energy homeostasis: resolving the paradox. Front Neuroendocrinol 2010, 31:79-84.
12. Gibson R.J., Stringer A.M. Chemotherapy-induced diarrhoea. Curr Opin Support Palliat Care 2009, 3:31-35.
13. Watts A.G. Understanding the neural control of ingestive behaviors: helping to separate cause from effect with dehydration-associated anorexia. Horm Behav 2000, 37:261-283.
14. Huschtscha L.I., Bartier W.A., Ross C.E., Tattersall M.H. Characteristics of cancer cell death after exposure to cytotoxic drugs in vitro. Br J Cancer 1996, 73:54-60.
15. Longo-Sorbello G.S., Bertino J.R. Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials. Haematologica 2001, 86:121-127.
16. Seigers R., Pourtau L., Schagen S.B., van Dam F.S., Koolhaas J.M., Konsman J.P., et al. Inhibition of hippocampal cell proliferation by methotrexate in rats is not potentiated by the presence of a tumor. Brain Res Bull 2010, 81:472-476.
17. Boukhettala N., Leblond J., Claeyssens S., Faure M., Le Pessot F., Bole-Feysot C., et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am J Physiol Endocrinol Metab 2009, 296(1):E182-E190.
18. Carneiro-Filho B.A., Lima I.P., Araujo D.H., Cavalcante M.C., Carvalho G.H., Brito G.A., et al. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Dig Dis Sci 2004, 49:65-72.
19. Chu K.U., Higashide S., Evers B.M., Rajaraman S., Ishizuka J., Townsend C.M., et al. Bombesin improves survival from methotrexate-induced enterocolitis. Ann Surg 1994, 220:570-576. discussion 576-7.
20. Hirotani Y., Yamamoto K., Ikeda K., Arakawa Y., Li J., Kitamura K., et al. Correlation between plasma glucagon-like peptide 2 levels and proliferative makers in small intestinal injury in rats induced by methotrexate administration. Biol Pharm Bull 2006, 29:2327-2330.
21. Leblond J., Le Pessot F., Hubert-Buron A., Duclos C., Vuichoud J., Faure M., et al. Chemotherapy-induced mucositis is associated with changes in proteolytic pathways. Exp Biol Med (Maywood) 2008, 233:219-228.
22. Verburg M., Renes I.B., Einerhand A.W., Buller H.A., Dekker J. Isolation-stress increases small intestinal sensitivity to chemotherapy in rats. Gastroenterology 2003, 124:660-671.
23. Morgan J.I., Curran T. Inducible proto-oncogenes of the nervous system: their contribution to transcription factors and neuroplasticity. Prog Brain Res 1990, 86:287-294.
24. Broberger C., Johansen J., Johansson C., Schalling M., Hökfelt T. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice. Proc Natl Acad Sci USA 1998, 95:15043-15048.
25. Broberger C., Johansen J., Brismar H., Johansson C., Schalling M., Hökfelt T. Changes in neuropeptide Y receptors and pro-opiomelanocortin in the anorexia (anx/anx) mouse hypothalamus. J Neurosci 1999, 19:7130-7139.
26. Fetissov S.O., Bergström U., Johansen J.E., Hökfelt T., Schalling M., Ranscht B. Alterations of arcuate nucleus neuropeptidergic development in contactin-deficient mice: comparison with anorexia and food-deprived mice. Eur J Neurosci 2005, 22:3217-3228.
27. Nilsson I., Lindfors C., Fetissov S.O., Hokfelt T., Johansen J.E. Aberrant agouti-related protein system in the hypothalamus of the anx/anx mouse is associated with activation of microglia. J Comp Neurol 2008, 507:1128-1140.
28. Wu Q., Howell M.P., Palmiter R.D. Ablation of neurons expressing agouti-related protein activates fos and gliosis in postsynaptic target regions. J Neurosci 2008, 28:9218-9226.
29. Friedman J.M., Halaas J.L. Leptin and the regulation of body weight in mammals. Nature 1998, 395:763-770.
30. Barbier M., Cherbut C., Aube A.C., Blottiere H.M., Galmiche J.P. Elevated plasma leptin concentrations in early stages of experimental intestinal inflammation in rats. Gut 1998, 43:783-790.
31. Phillips M.S., Liu Q., Hammond H.A., Dugan V., Hey P.J., Caskey C.J., et al. Leptin receptor missense mutation in the fatty Zucker rat. Nat Genet 1996, 13:18-19.
32. Bret-Dibat J.L., Bluthe R.M., Kent S., Kelley K.W., Dantzer R. Lipopolysaccharide and interleukin-1 depress food-motivated behavior in mice by a vagal-mediated mechanism. Brain Behav Immun 1995, 9:242-246.
33. Wren A.M., Bloom S.R. Gut hormones and appetite control. Gastroenterology 2007, 132:2116-2130.
34. Imai Y., Ibata I., Ito D., Ohsawa K., Kohsaka S. A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage. Biochem Biophys Res Commun 1996, 224:855-862.
35. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987, 162:156-159.
36. Adams J.C. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992, 40:1457-1463.
37. Hansen M.K., Krueger J.M. Subdiaphragmatic vagotomy blocks the sleep- and fever-promoting effects of interleukin-1beta. Am J Physiol 1997, 273:R1246-R1253.
38. Smith G.P., Jerome C., Cushin B.J., Eterno R., Simansky K.J. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981, 213:1036-1037.
39. St-Onge M.-P., Wang Z., Horlick M., Wang J., Heymsfield S.B. Dual-energy X-ray absorptiometry lean soft tissue hydration: independent contributions of intra- and extracellular water. Am J Physiol Endocrinol Metab 2004, 287:E842-E847.
40. Ericsson A., Liu C., Hart R.P., Sawchenko P.E. Type 1 interleukin-1 receptor in the rat brain: distribution, regulation, and relationship to sites of IL-1-induced cellular activation. J Comp Neurol 1995, 361:681-698.
41. Plata-Salaman C.R. Central nervous system mechanisms contributing to the cachexia-anorexia syndrome. Nutrition 2000, 16:1009-1012.
42. Matsuzaki J., Kuwamura M., Yamaji R., Inui H., Nakano Y. Inflammatory responses to lipopolysaccharide are suppressed in 40% energy-restricted mice. J Nutr 2001, 131:2139-2144.
43. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
44. Seigers R., Timmermans J., van der Horn H.J., de Vries E.F.J., Dierckx R.A., Visser L., et al. Methotrexate reduces hippocampal blood vessel density and activates microglia in rats but does not elevate central cytokine release. Behav Brain Res 2010, 207:265-272.
45. Konsman J.P., Veeneman J., Combe C., Poole S., Luheshi G.N., Dantzer R. Central nervous action of interleukin-1 mediates activation of limbic structures and behavioural depression in response to peripheral administration of bacterial lipopolysaccharide. Eur J Neurosci 2008, 28:2499-2510.
46. Laye S., Gheusi G., Cremona S., Combe C., Kelley K., Dantzer R., et al. Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression. Am J Physiol Regul Integr Comp Physiol 2000, 279:R93-R98.
47. van Dam A.M., Bauer J., Tilders F.J.H., Berkenbosch F. Endotoxin-induced appearance of immunoreactive interleukin-1[beta] in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience 1995, 65:815-826.
48. Hillebrand J.J., de Wied D., Adan R.A. Neuropeptides, food intake and body weight regulation: a hypothalamic focus. Peptides 2002, 23:2283-2306.
49. Cone R.D. Anatomy and regulation of the central melanocortin system. Nat Neurosci 2005, 8:571-578.
50. Fetissov S.O., Huang P., Zhang Q., Mimura J., Fujii-Kuriyama Y., Rannug A., et al. Expression of hypothalamic neuropeptides after acute TCDD treatment and distribution of Ah receptor repressor. Regul Pept 2004, 119:113-124.
51. Scarlett J.M., Jobst E.E., Enriori P.J., Bowe D.D., Batra A.K., Grant W.F., et al. Regulation of central melanocortin signaling by interleukin-1{beta}. Endocrinology 2007, 148:4217-4225.
52. Hahn T.M., Breininger J.F., Baskin D.G., Schwartz M.W. Coexpression of Agrp and NPY in fasting-activated hypothalamic neurons. Nat Neurosci 1998, 1:271-272.
53. Byrne L.C., Zhou Z., Tryggvason K., Hökfelt T., Fetissov S.O. Altered NPY and AgRP in membrane type-1 matrix metalloproteinase-deficient mice. NeuroReport 2004, 15:569-574.
54. Ding J.M., Carver W.C., Terracio L., Buggy J. Proto-oncogene c-fos and the regulation of vasopressin gene expression during dehydration. Brain Res Mol Brain Res 1994, 21:247-255.
55. Gottlieb H.B., Ji L.L., Jones H., Penny M.L., Fleming T., Cunningham J.T. Differential effects of water and saline intake on water deprivation-induced c-Fos staining in the rat. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1251-R1261.
56. Potts P.D., Ludbrook J., Gillman-Gaspari T.A., Horiuchi J., Dampney R.A.L. Activation of brain neurons following central hypervolaemia and hypovolaemia: contribution of baroreceptor and non-baroreceptor inputs. Neuroscience 1999, 95:499-511.
57. Sladek C.D., Olschowka J.A. Dehydration induces Fos, but not increased vasopressin mRNA in the supraoptic nucleus of aged rats. Brain Res 1994, 652:207-215.
58. Langhans W., Delprete E., Scharrer E. Mechanisms of vasopressin's anorectic effect. Physiol Behav 1991, 49:169-176.
59. Meyer A.H., Langhans W., Scharrer E. Vasopressin reduces food intake in goats. Exp Physiol 1989, 74:465-473.
60. Ikemura R., Matsuwaki T., Yamanouchi K., Nishihara M. Involvement of endogenous vasopressin in high plasma osmolality-induced anorexia via V1 receptor-mediated mechanism. J Vet Med Sci 2004, 66:951-955.
61. Antoni F.A. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993, 14:76-122.
62. Aoyagi T., Kusakawa S., Sanbe A., Hiroyama M., Fujiwara Y., Yamauchi J., et al. Enhanced effect of neuropeptide Y on food intake caused by blockade of the V(1A) vasopressin receptor. Eur J Pharmacol 2009, 622:32-36.
63. Jojart I., Laczi F., Laszlo F.A., Boda K., Csati S., Janaky T. Hyponatremia and increased secretion of vasopressin induced by vincristine administration in rat. Exp Clin Endocrinol 1987, 90:213-220.
64. Rinaman L., Vollmer R.R., Karam J., Phillips D., Li X., Amico J.A. Dehydration anorexia is attenuated in oxytocin-deficient mice. Am J Physiol Regul Integr Comp Physiol 2005, 288:R1791-R1799.
65. Verbalis J.G., Blackburn R.E., Hoffman G.E., Stricker E.M. Establishing behavioral and physiological functions of central oxytocin: insights from studies of oxytocin and ingestive behaviors. Adv Exp Med Biol 1995, 395:209-225.
66. McKinley M.J., Hards D.K., Oldfield B.J. Identification of neural pathways activated in dehydrated rats by means of Fos-immunohistochemistry and neural tracing. Brain Res 1994, 653:305-314.
67. Thornton S.N. Thirst and hydration: physiology and consequences of dysfunction. Physiol Behav 2010, 100:15-21.
68. Watts A.G., Boyle C.N. The functional architecture of dehydration-anorexia. Physiol Behav 2010, 100:472-477.
69. Shimommura Y., Shimizu H., Takahashi M., Uehara Y., Negishi M., Sato N., et al. Effects of peripheral administration of recombinant human interleukin-1 beta on feeding behavior of the rat. Life Sci 1990, 47:2185-2192.
70. Wang K., Waselenchuk L., Evered M.D. Stimulation of drinking by bacterial endotoxins in the rat. Physiol Behav 1993, 54:1005-1009.
71. Shaker Y. Thirst fever, with a characteristic temperature pattern in infants in Kuwait. Br Med J 1966, 1:586-588.
72. Widemann B.C., Adamson P.C. Understanding and managing methotrexate nephrotoxicity. Oncologist 2006, 11:694-703.
73. Boukhettala N., Ibrahim A., Aziz M., Vuichoud J., Saudan K.Y., Blum S., et al. A diet containing whey protein, free glutamine, and transforming growth factor-beta ameliorates nutritional outcome and intestinal mucositis during repeated chemotherapeutic challenges in rats. J Nutr 2010, 140:799-805.